Background:
Lower delivered dose of acute peritoneal dialysis (PD) in AKI requires less resources but raises concerns regarding adequate solute and water clearance. The relative merits of lower dose PD versus intermittent hemodialysis (HD) remain uncertain.
Methods:
A multicenter randomized controlled trial compared the outcomes between acute lower dosage PD (18-24 liters per day) and Intermittent HD (three times per week) from May 2018 to January 2021 in patients with AKI. The primary outcome was 28-day mortality rate. Secondary outcomes included 28-day dialysis-free survival and kidney recovery, metabolic profile, and procedure-related complications. Non-inferiority of PD to HD would be demonstrated if the upper bound of the 95% confidence interval (CI) on risk difference (PD-HD) in 28-day mortality rates between the two groups was less than 20%.
Results:
We included 157 patients (80 allocated to PD and 77 to intermittent HD). Before kidney replacement therapy initiation, baseline clinical characteristics between groups were comparable. Overall mean age was 57 ± 15 years old. The most frequent cause of AKI was sepsis (68%). There was no difference in 28-day mortality between acute PD and intermittent HD (50 vs 49%, risk difference 0.6 (95% CI -15.0,16.3), and 28-day dialysis-free survival (42% vs 37%, risk difference 4.6 (95% CI -11.1,20.3)). Mean weekly Kt/V urea were 2.11 ± 1.14 and 2.55 ± 1.11 in the PD and intermittent HD groups, respectively. The 7-day fluid balance of PD and intermittent HD patients were not significantly different. There was more frequent intradialytic hypotension in the intermittent HD group and more frequent hypokalemia in the PD group.
Conclusions:
In this study of patients with AKI, there was no significant difference in 28-day mortality between acute PD and intermittent HD.